A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension

doi:10.1038/s41440-020-0497-y

Editorial

. 2020 Sep;43(9):857-858.

doi: 10.1038/s41440-020-0497-y. Epub 2020 Jun 18.

A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension

Hiroshi Itoh¹

Affiliations

Affiliation

¹ Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. hiito@keio.jp.

PMID: 32555413
PMCID: PMC7301354
DOI: 10.1038/s41440-020-0497-y

Editorial

A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension

Hiroshi Itoh. Hypertens Res. 2020 Sep.

. 2020 Sep;43(9):857-858.

doi: 10.1038/s41440-020-0497-y. Epub 2020 Jun 18.

Author

Hiroshi Itoh¹

Affiliation

¹ Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, 35, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. hiito@keio.jp.

PMID: 32555413
PMCID: PMC7301354
DOI: 10.1038/s41440-020-0497-y

No abstract available

PubMed Disclaimer

Conflict of interest statement

The author declares that they have no conflicts of interest.

Cited by

COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19.
Shibata S, Kobayashi K, Tanaka M, Asayama K, Yamamoto E, Nakagami H, Hoshide S, Kishi T, Matsumoto C, Mogi M, Morimoto S, Yamamoto K, Mukoyama M, Kario K, Node K, Rakugi H. Shibata S, et al. Hypertens Res. 2023 Mar;46(3):589-600. doi: 10.1038/s41440-022-01134-5. Epub 2022 Dec 23. Hypertens Res. 2023. PMID: 36550205 Free PMC article. Review.
Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19.
Shibata S, Arima H, Asayama K, Hoshide S, Ichihara A, Ishimitsu T, Kario K, Kishi T, Mogi M, Nishiyama A, Ohishi M, Ohkubo T, Tamura K, Tanaka M, Yamamoto E, Yamamoto K, Itoh H. Shibata S, et al. Hypertens Res. 2020 Oct;43(10):1028-1046. doi: 10.1038/s41440-020-0515-0. Epub 2020 Jul 31. Hypertens Res. 2020. PMID: 32737423 Free PMC article. Review.
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic.
Correale M, Croella F, Leopizzi A, Mazzeo P, Tricarico L, Mallardi A, Fortunato M, Magnesa M, Ceci V, Puteo A, Iacoviello M, Di Biase M, Brunetti ND. Correale M, et al. Cardiovasc Drugs Ther. 2023 Apr;37(2):341-351. doi: 10.1007/s10557-021-07217-8. Epub 2021 Jul 30. Cardiovasc Drugs Ther. 2023. PMID: 34328581 Free PMC article. Review.
Reliable and Interpretable Mortality Prediction With Strong Foresight in COVID-19 Patients: An International Study From China and Germany.
Bai T, Zhu X, Zhou X, Grathwohl D, Yang P, Zha Y, Jin Y, Chong H, Yu Q, Isberner N, Wang D, Zhang L, Kortüm KM, Song J, Rasche L, Einsele H, Ning K, Hou X. Bai T, et al. Front Artif Intell. 2021 Sep 3;4:672050. doi: 10.3389/frai.2021.672050. eCollection 2021. Front Artif Intell. 2021. PMID: 34541519 Free PMC article.

References

1. Harari YN. Homo deus: a brief history of tomorrow. London, UK: Vintage; 2017. p. 2.
1. Hall G, Laddu DR, Phillips SA, Lavie CJ, Arena R. A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? Prog Cardiovasc Dis. 2020;S0033-0620:30077–3. doi: 10.1016/j.pcad.2020.04.005. - DOI - PMC - PubMed
1. Ohira T, Nakano H, Nagai M, Yumiya Y, Zhang W, Uemura M, et al. Changes in cardiovascular risk factors after the great east Japan earthquake. Asia Pac J Public Health. 2017;29:47S–55S. doi: 10.1177/1010539517695436. - DOI - PubMed
1. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin‐converting enzyme. Cloning and functional expression as a captopril‐insensitive carboxypeptidase. J Biol Chem. 2000;275:33238–43. doi: 10.1074/jbc.M002615200. - DOI - PubMed
1. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS‐CoV‐2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80. doi: 10.1016/j.cell.2020.02.052. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Harari YN. Homo deus: a brief history of tomorrow. London, UK: Vintage; 2017. p. 2.

[2] Harari YN. Homo deus: a brief history of tomorrow. London, UK: Vintage; 2017. p. 2.

[3] Hall G, Laddu DR, Phillips SA, Lavie CJ, Arena R. A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? Prog Cardiovasc Dis. 2020;S0033-0620:30077–3. doi: 10.1016/j.pcad.2020.04.005. - DOI - PMC - PubMed

[4] Hall G, Laddu DR, Phillips SA, Lavie CJ, Arena R. A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? Prog Cardiovasc Dis. 2020;S0033-0620:30077–3. doi: 10.1016/j.pcad.2020.04.005. - DOI - PMC - PubMed

[5] Ohira T, Nakano H, Nagai M, Yumiya Y, Zhang W, Uemura M, et al. Changes in cardiovascular risk factors after the great east Japan earthquake. Asia Pac J Public Health. 2017;29:47S–55S. doi: 10.1177/1010539517695436. - DOI - PubMed

[6] Ohira T, Nakano H, Nagai M, Yumiya Y, Zhang W, Uemura M, et al. Changes in cardiovascular risk factors after the great east Japan earthquake. Asia Pac J Public Health. 2017;29:47S–55S. doi: 10.1177/1010539517695436. - DOI - PubMed

[7] Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin‐converting enzyme. Cloning and functional expression as a captopril‐insensitive carboxypeptidase. J Biol Chem. 2000;275:33238–43. doi: 10.1074/jbc.M002615200. - DOI - PubMed

[8] Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin‐converting enzyme. Cloning and functional expression as a captopril‐insensitive carboxypeptidase. J Biol Chem. 2000;275:33238–43. doi: 10.1074/jbc.M002615200. - DOI - PubMed

[9] Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS‐CoV‐2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80. doi: 10.1016/j.cell.2020.02.052. - DOI - PMC - PubMed

[10] Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS‐CoV‐2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80. doi: 10.1016/j.cell.2020.02.052. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension

Affiliation

A new normal for hypertension medicine with coronavirus disease-2019 (COVID-19): proposal from the president of the Japanese Society of Hypertension

Author

Affiliation

Conflict of interest statement

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical